Literature DB >> 29618705

Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages.

Min Zhang1, Guo-Jun Zhao2, Kai Yin1, Xiao-Dan Xia1, Duo Gong1, Zhen-Wang Zhao1, Ling-Yan Chen1, Xi-Long Zheng3,4, Xiao-Er Tang5, Chao-Ke Tang1.   

Abstract

BACKGROUND: It has previously been demonstrated that apolipoprotein A-1 (apoA-1) binding protein (AIBP) promotes apoA-1 binding to ATP-binding cassette transporter A1 (ABCA1) and prevents ABCA1 protein degradation so as to inhibit foam cell formation. Because apoA-1 inhibits inflammatory signaling pathways, whether AIBP has an inhibitory effect on inflammatory signaling pathways in THP-1-derived macrophages is investigated.Methods and 
Results: Analysis of inflammation-related gene expression indicated that AIBP decreased lipopolysaccharide (LPS)-mediated macrophage inflammation. AIBP significantly prevented NF-κB nuclear translocation. Further, AIBP prevented the activation of mitogen-activated protein kinases (MAPKs), including p38 MAPK, extracellular-signal regulated kinase and c-Jun N-terminal kinase. AIBP decreased MyD88 expression at both mRNA and protein levels, but did not have any effect on TLR4 expression. Moreover, treatment with both AIBP and apoA-1 decreased the abundance of TLR4 in the lipid raft fraction. AIBP lacking 115-123 amino acids (∆115-123), however, did not have such effects as described for intact AIBP. In addition, knockdown of ABCA1 inhibited the effects of AIBP on inflammatory factor secretion.
CONCLUSIONS: These results suggest that AIBP inhibits inflammatory signaling pathways through binding to apoA-1 and stabilizing ABCA1, and subsequent alteration of lipid rafts and TLR4 in the cell membrane.

Entities:  

Keywords:  ATP-binding cassette transporter A1 (ABCA1); Apolipoprotein A-1 (apoA-1); Apolipoprotein A-1 binding protein (AIBP); Atherosclerosis; Inflammation

Mesh:

Substances:

Year:  2018        PMID: 29618705     DOI: 10.1253/circj.CJ-17-0877

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  20 in total

1.  AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.

Authors:  Soo-Ho Choi; Aaron M Wallace; Dina A Schneider; Elianne Burg; Jungsu Kim; Elena Alekseeva; Niki Dj Ubags; Carlyne D Cool; Longhou Fang; Benjamin T Suratt; Yury I Miller
Journal:  JCI Insight       Date:  2018-08-23

Review 2.  Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular diseases.

Authors:  Pooranee K Morgan; Longhou Fang; Graeme I Lancaster; Andrew J Murphy
Journal:  J Lipid Res       Date:  2019-08-30       Impact factor: 5.922

Review 3.  Regulation of lipid rafts, angiogenesis and inflammation by AIBP.

Authors:  Longhou Fang; Yury I Miller
Journal:  Curr Opin Lipidol       Date:  2019-06       Impact factor: 4.776

Review 4.  Apolipoprotein-AI and AIBP synergetic anti-inflammation as vascular diseases therapy: the new perspective.

Authors:  Ampadu O Jackson; Ganiyu A Rahman; Shiyin Long
Journal:  Mol Cell Biochem       Date:  2021-04-03       Impact factor: 3.396

5.  ABCA1, ABCG1, and Cholesterol Homeostasis.

Authors:  Xiao-Hua Yu; Chao-Ke Tang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 6.  Lipid rafts in glial cells: role in neuroinflammation and pain processing.

Authors:  Yury I Miller; Juliana M Navia-Pelaez; Maripat Corr; Tony L Yaksh
Journal:  J Lipid Res       Date:  2019-12-20       Impact factor: 5.922

7.  CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway.

Authors:  Jia-Hui Gao; Lin-Hao He; Xiao-Hua Yu; Zhen-Wang Zhao; Gang Wang; Jin Zou; Feng-Jiao Wen; Li Zhou; Xiang-Jun Wan; Da-Wei Zhang; Chao-Ke Tang
Journal:  J Lipid Res       Date:  2019-10-29       Impact factor: 5.922

Review 8.  AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis.

Authors:  Xueting Qiu; Jingmin Luo; Longhou Fang
Journal:  Curr Atheroscler Rep       Date:  2020-11-24       Impact factor: 5.113

Review 9.  APOA1: a Protein with Multiple Therapeutic Functions.

Authors:  Blake J Cochran; Kwok-Leung Ong; Bikash Manandhar; Kerry-Anne Rye
Journal:  Curr Atheroscler Rep       Date:  2021-02-16       Impact factor: 5.113

10.  Normalization of cholesterol metabolism in spinal microglia alleviates neuropathic pain.

Authors:  Juliana M Navia-Pelaez; Soo-Ho Choi; Luciano Dos Santos Aggum Capettini; Yining Xia; Ayelet Gonen; Colin Agatisa-Boyle; Lauriane Delay; Gilson Gonçalves Dos Santos; Glaucilene F Catroli; Jungsu Kim; Jenny W Lu; Benjamin Saylor; Holger Winkels; Christopher P Durant; Yanal Ghosheh; Graham Beaton; Klaus Ley; Irina Kufareva; Maripat Corr; Tony L Yaksh; Yury I Miller
Journal:  J Exp Med       Date:  2021-05-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.